Axa Has $13.21 Million Holdings in Mellanox Technologies, Ltd. (MLNX)

AXA lessened its stake in Mellanox Technologies, Ltd. (NASDAQ:MLNX) by 1.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 280,100 shares of the semiconductor producer’s stock after selling 4,400 shares during the period. AXA owned approximately 0.55% of Mellanox Technologies worth $13,207,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Legal & General Group Plc boosted its holdings in Mellanox Technologies by 4.6% in the 2nd quarter. Legal & General Group Plc now owns 4,488 shares of the semiconductor producer’s stock worth $194,000 after buying an additional 199 shares during the period. UBS Asset Management Americas Inc. boosted its holdings in Mellanox Technologies by 4.6% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 21,011 shares of the semiconductor producer’s stock worth $910,000 after buying an additional 917 shares during the period. Swiss National Bank boosted its holdings in Mellanox Technologies by 2.2% in the 2nd quarter. Swiss National Bank now owns 73,821 shares of the semiconductor producer’s stock worth $3,196,000 after buying an additional 1,600 shares during the period. State Street Corp boosted its holdings in Mellanox Technologies by 5.3% in the 2nd quarter. State Street Corp now owns 53,753 shares of the semiconductor producer’s stock worth $2,329,000 after buying an additional 2,725 shares during the period. Finally, SG Americas Securities LLC bought a new position in Mellanox Technologies in the 2nd quarter worth $122,000. 60.81% of the stock is owned by institutional investors and hedge funds.

Mellanox Technologies, Ltd. (MLNX) traded up $1.80 during trading hours on Thursday, reaching $64.95. 458,738 shares of the company were exchanged, compared to its average volume of 411,905. Mellanox Technologies, Ltd. has a 12 month low of $40.70 and a 12 month high of $66.15. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.12 and a quick ratio of 2.78. The stock has a market capitalization of $3,320.00, a PE ratio of -405.94, a price-to-earnings-growth ratio of 2.50 and a beta of 0.62.

Mellanox Technologies (NASDAQ:MLNX) last posted its earnings results on Wednesday, October 25th. The semiconductor producer reported $0.71 EPS for the quarter, beating the Zacks’ consensus estimate of $0.64 by $0.07. The company had revenue of $225.70 million during the quarter, compared to analysts’ expectations of $226.74 million. Mellanox Technologies had a negative net margin of 0.92% and a positive return on equity of 4.76%. Mellanox Technologies’s revenue for the quarter was up .7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.93 earnings per share. equities analysts anticipate that Mellanox Technologies, Ltd. will post 0.84 earnings per share for the current fiscal year.

MLNX has been the topic of several research analyst reports. Zacks Investment Research cut shares of Mellanox Technologies from a “hold” rating to a “sell” rating in a research note on Wednesday, September 27th. Barclays cut shares of Mellanox Technologies from an “overweight” rating to an “underweight” rating and decreased their price target for the stock from $50.00 to $48.00 in a research note on Monday, October 9th. KeyCorp reiterated a “hold” rating on shares of Mellanox Technologies in a research note on Tuesday, October 17th. JPMorgan Chase & Co. cut shares of Mellanox Technologies from an “overweight” rating to a “neutral” rating in a research note on Thursday, October 26th. Finally, Stifel Nicolaus cut their price target on shares of Mellanox Technologies from $56.00 to $53.00 and set a “buy” rating on the stock in a report on Thursday, October 26th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $58.60.

In other news, Director Amal M. Johnson sold 2,857 shares of the firm’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $57.60, for a total value of $164,563.20. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Yakov (Jacob) Shulman sold 2,706 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $46.32, for a total transaction of $125,341.92. The disclosure for this sale can be found here. In the last three months, insiders have sold 260,718 shares of company stock valued at $13,455,300. 6.05% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://stocknewstimes.com/2018/01/11/mellanox-technologies-ltd-mlnx-stake-lowered-by-axa.html.

Mellanox Technologies Profile

Mellanox Technologies, Ltd. is a fabless semiconductor company. The Company is an integrated supplier of interconnect products and solutions based on the InfiniBand and Ethernet standards. The Company operates in the development, manufacturing, marketing and sales of interconnect products segment. Its products facilitate data transmission between servers, storage systems, communications infrastructure equipment and other embedded systems.

Institutional Ownership by Quarter for Mellanox Technologies (NASDAQ:MLNX)

Receive News & Ratings for Mellanox Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mellanox Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply